Table of Contents

Part 1. Background.
Introduction.
Evidence Based Medicine: Levels of Evidence and Evaluation Systems.
Decision Analytic Techniques.
Decision Making The Surgeons Perspective.
Decision MakingThe Patients Perspective.
Part 2. Lung.
PET for Mediastinal Restaging of Patients with Non Small Cell Lung Cancer after Induction Therapy.
Optimal Initial Pathologic Mediastinal Staging of Lung Cancer EUS EBUS Mediastinoscopy.
VATS vs Open Lobectomy for Early Stage Non Small Cell Lung Cancer.
N2 Disease Discovered at Thoracotomy Resect or Abort.
Pulmonary Function Alterations After Induction Therapy for Lung Cancer Preoperative Considerations.
Lobectomy After Induction Therapy for Stage IIIA NSCLC in the Presence of Persistent N2 Disease.
Pneumonectomy After Induction Therapy for Stage IIIA Non small cell Lung Cancer.
Segmentectomy Versus Lobectomy for Stage I Lung Cancer in Patients with Good Pulmonary Function.
Optimal Therapy for Patients with Marginal Lung Function and Peripheral Stage I Lung Cancer.
VATS Versus Thoracotomy for Major Lung Resection After Induction Therapy.
Chest Tube Management After Lung Resection.
Management of the Pleural Space Early After Pneumonectomy.
Perioperative Prophylaxis Against Venous Thrombo Embolism in Major Lung Resection.
Perioperative Arrhythmia Prophylaxis for Major Lung Resection.
For Whom Is Lung Volume Reduction Surgery Effective.
Support Therapy for Lung Failure.
Part 3. Esophagus.
Optimal Management of Barrett Esophagus with High Grade Dysplasia.
Induction Therapy for Resectable Esophageal Cancer.
Optimal Surgical Approach to Esophagectomy for Cancer.
Extent of Lymph Node Dissection in Esophageal Cancer.
Salvage Esophagectomy for Persistent Disease After Definitive.
Chemoradiotherapy.
Barrett Mucosa in the Cervical Remnant After Esophagectomy for Cancer.
Partial or Total Fundoplication for GERD in the Presence of Impaired Esophageal Motility.
Surgical Management of Non acid Reflux Unresponsive to Medical Therapy.
Prophylactic Antireflux Surgery in Lung Transplantation.
Optimal Initial Therapy for Achalasia.
Stenting for Esophageal Perforation and Anastomotic Leak.
Lengthening Gastroplasty for Managing GERD and Giant Paraesophageal Hernia.
Optimal Therapy for Cricopharyngeal Diverticula.
Management of Distal Esophageal Pulsion Diverticula.
Part 4. Diaphragm.
Giant Paraesophageal Hernia: Optimal Surgical Approach.
Synthetic Reinforcement of Diaphragm Closure for Large Hiatal Hernia Repair. Part 5. Airway.
Stents for Benign Airway Obstruction.
Tracheal Reconstruction with Autologous and Engineered Tissues.
Optimal Management of Malacic Airway Syndromes.
Carinal Resection for Cancer.
Part 6. Pleura and Pleural Space.
Use of Sealants to Reduce Air Leak Duration and Hospital Stay After Lung Resection.
Optimal Initial Therapy for Pleural Empyema.
Management of Malignant Pleural Effusion: Sclerosis or Chronic Tube Drainage.
The Role of VATS Pleurodesis in the Management of Initial Primary Spontaneous Pneumothorax.
Malignant Pleural Mesothelioma: Patient Selection for Pleurectomy.
Malignant Pleural Mesothelioma: Patient Selection for Extrapleural Pneumonectomy.
Part 7. Mediastinum.
Thymectomy for Myathenias Gravis.
Optimal Surgical Approach and Extent of Resection of the Thymus in Patients with Myasthenia Gravis.
The Optimal Approach for Resection of Encapsulated Thymoma: Open Versus VATS.
Management of Residual Disease After Therapy for Mediastinal Germ Cell Tumor and Normal Serum Markers.
Symptomatic Malignant Pericardial Effusion: Surgical or Percutaneous Drainage.
Bronchogenic and Pericardial Cysts: Resect or Observe.
Patient Selection and Optimal Extent of Surgery for Hyperhidrosis.
Part 8. Chest Wall.
Pectus Excavatum in the Adult: Current Treatment Modalities.
Traumatic Rib Fracture: Conservative Therapy or Surgical Fixation.